UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029796
Receipt number R000034047
Scientific Title Randomized, double-blind study to evaluate the sensitivity and painfulness of different concentration of iodine solution during endoscopic examination to detect esophageal squamous epithelial tumor.
Date of disclosure of the study information 2017/12/16
Last modified on 2019/05/07 19:16:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized, double-blind study to evaluate the sensitivity and painfulness of different concentration of iodine solution during endoscopic examination to detect esophageal squamous epithelial tumor.

Acronym

Randomized, double-blind study to evaluate the sensitivity and painfulness of different concentration of iodine solution during endoscopic examination to detect esophageal squamous epithelial tumor.

Scientific Title

Randomized, double-blind study to evaluate the sensitivity and painfulness of different concentration of iodine solution during endoscopic examination to detect esophageal squamous epithelial tumor.

Scientific Title:Acronym

Randomized, double-blind study to evaluate the sensitivity and painfulness of different concentration of iodine solution during endoscopic examination to detect esophageal squamous epithelial tumor.

Region

Japan


Condition

Condition

esophageal squamous epithelial tumor

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

to evaluate the sensitivity and painfulness of different concentration of iodine solution during endoscopic examination to detect esophageal squamous epithelial tumor.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

painfulness of different concentration of iodine solution

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Dose comparison

Stratification

NO

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

different concentration of iodine solution(1%)

Interventions/Control_2

different concentration of iodine solution(2%)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

1)The patients who have a superficial esophageal squamous cell carcinoma
2)A patient undergoing endoscopic examination after ESD for superficial esophageal cancer.
3)A past history of head and neck squamous cell cancer.
4)A patient who has more than six points in HRA-F score for esophageal cancer
5)A patient aged 20 years or older at the time of enrollment.
6)A patient who has provided written informed consent to participate in this study.

Key exclusion criteria

1) The patients treated by chemotherapy or radiotherapy and surgery for esophageal SCC or head and neck cancer.
2) A history of iodine hypersensitivity
3) A patient with sedative drugs
4) Pregnant or breast-feeding woman
5) A patient who has not provided written informed consent to participate in this study.
6) In certain circumstances that the researchers determined it was not suitable for the research

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Okada

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Division name

Department of Gastroenterology and Hepatology

Zip code

700-8558

Address

2-5-1 Shikata, Okayama 700-8558, Japan

TEL

086-235-7218

Email

hiro@md.okayama-u.ac.jp


Public contact

Name of contact person

1st name Tatsuhiro
Middle name
Last name Gotoda

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Division name

Department of Gastroenterology and Hepatology

Zip code

700-8558

Address

2-5-1 Shikata, Okayama 700-8558, Japan

TEL

086-235-7218

Homepage URL


Email

nkjbm234@yahoo.co.jp


Sponsor or person

Institute

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Gastroenterology and Hepatology

Institute

Department

Personal name



Funding Source

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Gastroenterology and Hepatology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Gastroenterology and Hepatology

Address

2-5-1 Shikata, Okayama 700-8558, Japan

Tel

086-235-7218

Email

nkjbm234@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 10 Month 30 Day

Date of IRB

2018 Year 02 Month 20 Day

Anticipated trial start date

2017 Year 12 Month 16 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 11 Month 01 Day

Last modified on

2019 Year 05 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034047


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name